![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 21, 19206-19212, May 24, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, February 1, 2002, and in revised form, March 6, 2002
Discoidin domain receptor 2 (DDR2) is an unusual
receptor tyrosine kinase in that its ligand is fibrillar collagen
rather than a growth factor-like peptide. We examined signal
transduction pathways of DDR2. Here we show that DDR2 is also unusual
in that it requires Src activity to be maximally
tyrosine-phosphorylated, and that Src activity also promotes
association of DDR2 with Shc. The interaction with Shc involves a
portion of Shc not previously implicated in interaction with receptor
tyrosine kinases. These results identify Src kinase and the adaptor
protein Shc as key signaling intermediates in DDR2 signal transduction.
Furthermore, Src is required for DDR2-mediated transactivation of the
matrix metalloproteinase-2 promoter. The data support a model in
which Src and the DDR2 receptor cooperate in a regulated fashion to direct the phosphorylation of both the receptor and its targets.
Receptor tyrosine kinases
(RTKs)1 of the discoidin
domain receptor (DDR) family are unlike most RTKs, in that they
do not use typical peptide growth factors as ligands; instead, they
signal in response to fibrillar collagens (1, 2), establishing the DDR
family as receptors for extracellular matrix molecules. Thus far, two
DDR receptors have been identified, DDR1 and DDR2. DDR1 is primarily
expressed in epithelial cells in the brain, gastrointestinal tract,
lung, and kidney, whereas DDR2 is expressed in interstitial cells in
the heart, skeletal muscle, lung, brain, and kidney (3). DDR1 and DDR2
are differentially activated by collagens. DDR1 is activated primarily
by collagen types I, II, III, V, and XI, whereas DDR2 is activated
mainly by collagen types I and III (1, 2, 4).
In addition to their unique ligand specification, several other
features distinguish DDR receptors from other RTKs. The kinetics of DDR
receptor activation by collagens differs significantly from other RTKs
in response to their cognate ligands. For example, platelet-derived
growth factor (PDGF) or epidermal growth factor stimulate receptor
activation within seconds (4). In contrast, tyrosine phosphorylation of
DDR receptors can be detected only after prolonged exposure to collagen
(approximately 30 min), and then phosphorylation is sustained for an
extended period (more than 16 h) (2, 5). This unique slow-on,
slow-off phenomenon and receptor specificity raise important questions
about the nature of downstream intracellular signals mediating the
effects of DDR2.
Receptor tyrosine kinases contain a catalytic domain that can
autophosphorylate one or more tyrosine residues typically located in
the noncatalytic region of the receptor. These phosphorylations lead to
generation of docking sites for SH2 and PTB domains of signaling
molecules that associate with the receptors (6). For example, PDGF
receptor and fibroblast growth factor receptor associate with signaling
molecules such as phospholipase C- In this study, we have explored intracellular pathways mediating DDR2
signaling, and report that DDR2 signaling is propagated through
interaction with both the Src non-receptor tyrosine kinase and the
adaptor molecule Shc. Furthermore, we demonstrate that these signals
mediate transactivation of the matrix metalloproteinase-2 (MMP-2) promoter.
Plasmids and Cell Lines--
We used HSC-T6 cells,
an activated rat hepatic stellate cell (i.e. myofibroblast)
line (7), COS7 cells, Src/Yes/Fyn triple-null cells (SYF) (8), and skin
fibroblasts that were isolated from DDR2
pUSE wild type Src, pUSE activated Src (CA Src), and pUSE dominant
negative Src (DN Src) were purchased from Upstate Biotechnology, Inc.
pMT21DDR2 encodes the mouse wild type DDR2 sequence. pMT21FcDDR2 encodes a chimeric protein in which the DDR2 ectodomain is replaced by
the Fc portion of human immunoglobulin. This FcDDR2 chimera produces
spontaneous aggregation of the DDR2 cytoplasmic domain, leading to
activation of tyrosine kinase activity. pMT21FcDDR2KE encodes a mutant
FcDDR2 cDNA containing a K608E. pMT21FcDDR2Y471F encodes a mutant
FcDDR2 cDNA containing a Y471F. pMT21FcDDR2KEY471F encodes double
mutant FcDDR2 cDNA containing K608E and Y471F.
Cell Lysis, Immunoprecipitation, and Immunoblotting--
Each
cell line was maintained in Dulbecco's modified Eagle's medium
supplemented with 10% fetal calf serum and grown in the presence of
penicillin and streptomycin. FcDDR2 and CA or DN Src were cotransfected
in COS7 cells using LipofectAMINE (Invitrogen) in Opti-MEM
serum-free medium at 37 °C for 24 h. HSC-T6 cells and COS7
cells were serum-starved in Dulbecco's modified Eagle's medium for
16 h and then stimulated with collagen type I (Becton Dickinson)
for 2 h.
Cells on 10-cm diameter culture dishes were rinsed twice in PBS
(4 °C) and lysed in 0.5 ml of the lysis buffer (50 mM
HEPES, pH 7.5, 150 mM NaCl, 1.5 mM
MgCl2, 5 mM EDTA, 10% glycerol, 1% Triton
X-100, 0.5% Nonidet P-40, 10 mM NaF, 1 mM
Na3VO4, and protease inhibitor mixture (Roche
Molecular Biochemicals)), and insoluble material was removed by
centrifugation (15,000 × g, 10 min) at 4 °C. After
total cell protein in lysates from serum-starved cells was determined
by a Bradford assay (Bio-Rad), antibodies were added to the cell
lysates and incubated for 2 h at 4 °C, followed by
precipitation on protein A-agarose beads (Sigma). The
immunoprecipitated proteins were washed at 4 °C in the lysis buffer
prior to direct analysis by SDS-polyacrylamide gel electrophoresis
(PAGE) (8% acrylamide gel). For immunoblotting, proteins were
transferred to membranes overnight at 50 mA. The membranes were washed
in Tris-buffered saline plus Tween (25 mM Tris-HCl, pH 7.6, 50 mM NaCl, 0.05% or 0.1% Tween 20) and placed in
blocking buffer (Tris-buffered saline plus Tween containing 8% fetal
calf serum or 5% milk) for 1 h at room temperature. The blots
were incubated with 1:20,000 dilution of anti-phosphotyrosine Ab (4G10,
Upstate Biotechnology, Inc.), 1:1,000 dilution of anti-DDR2 Ab (R2-JM,
R2B), anti-Shc Ab (Upstate Biotechnology, Inc.), and anti-Src Ab
(Upstate Biotechnology, Inc.) for 1 h at room temperature.
Bound primary antibody was visualized by chemiluminescent horseradish
peroxidase substrate (Pierce) with horseradish peroxidase-conjugated
anti-mouse antibody (Rockland) or protein A (Bio-Rad) at 1:15,000
dilution. Membranes were stripped of bound antibodies by incubation in
the buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 100 mM Yeast Two-hybrid Screening--
The
Saccharomyces cerevisiae yeast reporter strain,
L40, has the following genotype: MATa trp1
leu2 his3
LYS2::lexA-HIS3 URA3::lexA-lacZ. L40 were
grown at 30 °C in YPAD (1% yeast extract, 2% Bacto-peptone, 2%
glucose, and 0.1 mg/ml adenine).
To identify a DDR2 cytoplasmic domain interacting clone, a two-hybrid
screen was performed (10). Briefly, a 500-ml culture of L40 expressing
the LexA-DDR2 cytoplasmic domain with Src was grown in synthetic medium
lacking tryptophan to select for the bait plasmid
(pBTM116[Src]-DDR2). The cells were then transformed with 500 µg of
DNA derived from a human skeletal muscle cDNA library (CLONTECH catalog no. HL4047AH). 6 × 106 transformants were obtained in the screen. The
transformants were grown in liquid selective medium of 16 h at
30 °C to increase the efficiency of expression of the
HIS3 reporter gene. The cells were then plated onto
synthetic medium plates lacking tryptophan, leucine, histidine, uracil,
and lysine. After 3 days at 30 °C, the colonies were picked and
streaked for
The prey plasmid DNA was isolated according to manufacturer's
instructions using YEASTMAKER Yeast Plasmid Isolation kit
(CLONTECH). Isolated prey plasmid DNAs were
sequenced using an ABI Prism 373 automated fluorescent DNA sequencer
(PerkinElmer). DNA data base searches were performed using the BLASTA
program. These prey plasmid DNAs were simultaneously reintroduced into
L40 in combination with either the original bait or controls
(pBTM116-lamin, pBTM116[src], pBTM116-DDR2) followed by
MMP-2 Promoter Activity--
Constructs extending 1686 bp
upstream of the translation start site of the MMP-2 gene were subcloned
into the promoterless luciferase expression vector pGL2-basic (Promega)
(11). In all transfections the pRL-null vector expressing the
Renilla luciferase enzyme cDNA (Promega) was included to
control for transfection efficiency using dual luciferase detection.
Transient transfections of subconfluent cell cultures were performed
with 4 µl of FuGENE (Roche Molecular Biochemicals) according to the
manufacturer's instructions. Skin fibroblasts were cotransfected with
0.5 µg of MMP-2 promoter constructs cDNA, 0.5 µg of CA or DN
Src cDNA, and 15 ng of the Renilla cDNA. Cells were
cultured in the presence of collagen type I with or without Src kinase inhibitor SU6656 for 24 h after transfection. Luciferase activity was assessed using the dual luciferase assay kit (Promega). Final values were corrected for efficiency of transfection as assessed by
Renilla activity.
Statistics--
Data were expressed as mean values ± S.D.
The results were analyzed according to unpaired Student's t test.
DDR2 Associates with Src, and Its Phosphorylation Is Regulated by
Src--
To identify endogenous DDR2 expression and its signaling
pathway, we initially utilized a rat hepatic stellate cell line
(HSC-T6), as we previously identified DDR2 expression in this cell type by homology PCR for receptor tyrosine kinases (12). These cells were
cultured with or without collagen type I for 2 h.
Immunoprecipitation of cell lysates was performed using a polyclonal
antibody (R2-JM) to the DDR2 juxtamembrane domain, followed by Western
blot (WB) with either anti-DDR2 or an anti-phosphotyrosine antibody
(Fig. 1). Immunoprecipitation/WB for
anti-DDR2 confirmed DDR2 expression with and without collagen (Fig. 1,
lanes 1 and 2), and WB with anti-phosphotyrosine
demonstrated that DDR2 is phosphorylated following exposure to type I
collagen (Fig. 1, lanes 3 and 4). Interestingly,
WB for anti-phosphotyrosine showed another band of ~60 kDa (Fig. 1,
asterisk, lane 4). Prior to the identification of
DDR2 as a collagen receptor, cell interactions with collagen had been
ascribed almost exclusively to integrins, a family of heterodimeric
receptors composed of
Regulation of several receptor tyrosine kinases by Src kinase has been
reported (14). To initially explore the role of Src in DDR2 activation,
we tested the effect of a specific Src family kinase inhibitor, SU6656
(SUGEN) (15). COS 7 cells expressing recombinant DDR2 were pretreated
with incremental concentrations of SU6656, followed by stimulation with
type I collagen. DDR2 autophosphorylation stimulated by collagen was
clearly inhibited in a dose-dependent manner by SU6656 with
an IC50 of ~2 µM (Fig. 2). This finding suggests that DDR2
activation could be Src-dependent.
To examine the role of Src on DDR2 activation more directly, we
performed experiments in which the phosphorylation state of a
constitutively dimerized form of DDR2 (FcDDR2, a dimerized DDR kinase
resulting from the replacement of the DDR2 extracellular domain with
the Fc region of human IgG) was analyzed in the presence of CA or DN
Src. As shown in Fig. 3D,
FcDDR2 is much more active than unstimulated DDR2 and appears to be as
active as fully stimulated DDR2. In COS7 cells that were cotransfected
with FcDDR2 and CA Src, markedly increased tyrosine phosphorylation of
FcDDR2 was detectable (Fig. 3A, lane 4), compared
with that in COS7 cells transfected with only FcDDR2 (Fig.
3A, lane 3). Some phosphorylation was still
detected in cells transfected only with FcDDR2 without CA Src, which
could reflect autophosphorylation because of its dimeric structure
and/or the activity of endogenous Src kinase. Importantly, the ability
of Src to promote tyrosine phosphorylation of DDR2 depends on intact
kinase activity of the DDR2 receptor, because CA Src promoted much less
tyrosine phosphorylation of a kinase-dead form of DDR2 (Fig.
3A, lane 6). Thus, the catalytic activity of DDR2
and Src seem to synergistically promote tyrosine phosphorylation of
DDR2.
Next, COS7 cells were cotransfected with a dominant negative Src and
FcDDR2, which inhibited tyrosine phosphorylation of FcDDR2 compared
with that in COS7 cells transfected with only FcDDR2 (Fig.
3B). Importantly, cotransfection of dominant negative Src also inhibited the tyrosine phosphorylation of full-length DDR2 stimulated by type I collagen (Fig. 3C, lanes 7 and 8).
To further establish the physiological relevance of the interaction
between DDR2 and Src kinase, SYF and wild type fibroblasts were
stimulated by collagen type I. As shown in Fig.
4, DDR2 phosphorylation by collagen type
I stimulation was delayed and decreased in SYF cells. In particular,
the upper band in WB for anti-phosphotyrosine, which represents a
highly phosphorylated form of DDR2, is diminished in SYF knockout cells
(Fig. 4, lanes 7 and 8).
DDR2 Associates with Shc in a Src-dependent
Manner--
To further explore interactions between DDR2 and Src, we
next utilized the yeast two-hybrid system to clone proteins that bind
to phosphorylated DDR2 cytoplasmic domain in the presence of Src
kinase. The bait vector encoded the cytoplasmic domain of DDR2 (fused
to LexA) but was also modified to include the expression of
constitutively active Src to phosphorylate the expressed LexA-DDR2 fusion protein (Fig. 5A). To
first test whether Src tyrosine kinase induced phosphorylation of the
DDR2 cytoplasmic domain in yeast, we performed an anti-phosphotyrosine
blot. Lysates of yeast cells transformed with control bait
(pBTM116-lamin, pBTM116[src], and pBTM116-DDR2) and cells expressing
LexA-DDR2 fusion together with Src (pBTM116 [src] DDR2) were
precipitated by anti-DDR2 (R2B), followed by WB with anti-DDR2,
anti-LexA, and/or anti-phosphotyrosine (Fig. 5A). Immunoblot
with anti-DDR2 or anti-LexA demonstrated a band corresponding to the
expected size of the LexA-DDR2 cytoplasmic domain fusion protein in the
yeast transformed with either pBTM116-DDR2 or pBTM116[src]-DDR2 bait
vector; however, phosphorylation was confined to the fusion protein
co-expressed with Src kinase.
To identify potential interacting prey proteins by yeast two-hybrid, we
chose a commercial library from skeletal muscle cells, where DDR2 is
expressed. From the ~6 × 106 transformants that
were screened with the DDR2 bait, 46 colonies were positive for
transcriptional activation. Among these was a 2.5-kbp cDNA encoding
part of the Shc adaptor protein. As shown in Fig. 5B, Shc
has three isoforms (46, 52, and 66 kDa) (16, 17). CH1, SH2, and a part
of PTB domains are common to each of these. The region of Shc
identified by yeast two-hybrid overlapped almost exactly with CH1 and
SH2 domains, which are included in all three isoforms, but surprisingly
did not include the PTB domain, which has generally been involved in
previously identified interaction of Shc with other receptor tyrosine kinases.
To establish that Src tyrosine kinase is necessary for Shc association
with DDR2, Shc was cotransformed with each control bait vector
(pBTM116-lamin, pBTM116[src], or pBTM116-DDR2) to assay for
complementation as assessed by
We next investigated which domain(s) of Shc were required for
interaction with DDR2. The sequences of PTB, CH1, SH2, (PTB+CH1), (CH1+SH2), and full-length Shc were inserted into the pGAD vector as an
in-frame fusion with a hemagglutinin tag to create a panel of putative
prey molecules. Three control bait vectors and the original vector were
cotransformed with each prey vector into L40 yeast. As shown in Table
I,
To confirm the association of Shc with DDR2 in mammalian cells, we used
skin fibroblasts from DDR2 knockout mice (9), which were reconstituted
by retroviral infection with green fluorescent protein, wild type mouse
DDR2, or a kinase-dead DDR2 mutant (Fig. 6). Each of these cell populations was
cultured with or without collagen type I (20 µg/ml). Cells lysates
were precipitated by anti-DDR2 polyclonal antibody, followed by Western
blot with anti-DDR2, anti-phosphotyrosine, and/or anti-Shc.
Immunoprecipitation/WB demonstrated that Shc associated with DDR2 when
cells expressing wild type DDR2 were stimulated with collagen type I
(Fig. 6, lane 4). Shc association with DDR2 did not occur
when cells expressing the kinase-dead mutant were stimulated with
collagen type I (Fig. 6, lane 6).
We further investigated the requirement for Src kinase for Shc to
associate with DDR2. FcDDR2 and dominant negative Src were cotransfected in COS7 cells. Cells lysates were precipitated with protein A, followed by Western blot with anti-DDR2,
anti-phosphotyrosine or anti-Shc. As shown in Fig.
7A, the phosphorylated FcDDR2
was dephosphorylated by dominant negative Src. Autophosphorylated FcDDR2 associated with Shc (Fig. 7A, lane 3),
whereas FcDDR2 dephosphorylated by dominant negative Src did not
support the Shc-DDR2 interaction (Fig. 7A, lane
4). Furthermore, the Src kinase inhibitor, SU6656, partially
inhibited phosphorylation of DDR2 by collagen I stimulation, while
completely inhibiting Shc association with DDR2 (Fig. 7B, lanes 4 and 5). On the other hand, FcDDR2 was
highly phosphorylated by overexpressed Src, which in turn was highly
associated with Shc (Fig. 8, lane
7).
To identify residues in DDR2 critical for Src/Shc interaction, we
generated a Y471F mutant in the juxtamembrane region of DDR2 to
investigate whether this site is critical for Src/Shc interaction based
on the following reasons. 1) A data base search, by using
"Scansite" of the Division of Signal Transduction, Harvard Institutes of Medicine (scansite.mit.edu/), identified Tyr-471 as a candidate tyrosine critical for the Src/Shc interaction. 2) Src
binds to phosphotyrosine residues in the juxtamembrane region of other
RTKs like PDGF-R
Plasmids encoding a point mutation of Y471F and double point mutations
of K608E and Y471F of FcDDR2 were cotransfected with or without wild
type Src in COS7 cells. Cell lysates were precipitated with protein A,
followed by Western blot with anti-DDR2, anti-phosphotyrosine, and
anti-Shc. The Y471F mutation of FcDDR2 moderately decreased DDR2
phosphorylation with or without Src. However, the K608E and Y471F
double mutation of FcDDR2 dramatically decreased phosphorylation by
90%. Although Shc association with DDR2 was dependent on Src, it was
also decreased by the Y471F mutation. The Y471F mutation decreased its
association with Shc by 70%. The K608E/Y471F double mutations reduced
Shc association by 90% (Fig. 8).
DDR2 Signaling Mediates MMP-2 Promoter Activity--
To explore
the biological consequences of DDR2 signaling and the role of Src
kinase, we examined whether DDR2 stimulation by Src up-regulated the
promoter activity of MMP-2, which we have recently identified as a
downstream target of DDR2 (21). To do so, DDR2 Adhesion to extracellular matrices and to other cells is mediated
by a diverse family of receptors, the best characterized being
integrins (13), cadherins (22), selectins (23), and cell adhesion
molecules (24). Src kinases have been implicated in adhesion
events regulated by these receptors (25). Src family kinases also
communicate with many different RTKs (14). The biochemical connections
between these different receptors and Src family kinases include
phosphorylation of Src family kinase, association with the RTK,
activation of Src kinases, and phosphorylation of the RTK.
Interestingly, the DDR family of RTKs have recently been found to
represent a new receptor class that responds to the extracellular
matrix in particular by binding collagen (1, 2). Thus, the interaction
between DDRs and other classes of matrix receptors, as well as the
sharing of downstream signaling pathways such as Src, must be explored.
In this study, we have shown that endogenously expressed DDR2 receptors
in an activated hepatic stellate cell line (HSC-T6) are associated with
the non-receptor tyrosine kinase Src. Furthermore, we demonstrate that
Src is requisite for maximal DDR2 tyrosine phosphorylation and leads to
additional association with the adaptor molecule Shc, resulting in
increased MMP-2 promoter activity.
There is minimal information about downstream signaling molecules for
DDR receptors. Shc has recently been shown to associate with DDR1 (2),
although the interacting region of Shc for DDR1 differs from that used
by Shc for DDR2. Shc is expressed as three alternatively spliced
adapter proteins, which share an N-terminal PTB domain, a central
glycine sequence, and C-terminal SH2 domain as shown in Fig.
5B. Shc proteins are tyrosine-phosphorylated by receptor
tyrosine kinases and bind to phosphotyrosine residues on those
receptors. The b isoform of DDR1 has an additional 37-amino acid
sequence inserted by alternative splicing into the juxtamembrane domain
containing an LXNPXY sequence (26). Upon
collagen-mediated receptor activation, the tyrosine in the
LXNPXY sequence becomes phosphorylated, providing
a binding site for PTB domain of Shc. In contrast, we find by yeast
two-hybrid system that DDR2 associates with CH1-SH2 domains of Shc but
not its PTB, because the portion of Shc containing both the CH1+SH2
domains is the minimal region required to interact with phosphorylated
DDR2. Consistent with DDR2 interacting with non-PTB portion of Shc,
DDR2 lacks the NPXY site by which Shc PTB domain has been shown to bind
DDR1 and other receptors. We additionally establish that
phosphorylation of DDR2 receptor is necessary for association with Src,
and that the Tyr-239/Tyr-240 residues in the CH1 domain of Shc are also
phosphorylated by Src (27). Shc phosphorylation at tyrosine residues in
the CH1 domain (Tyr-239, Tyr-240, and Tyr-317) may also be necessary
for the association with DDR2, particularly because these residues are preserved in all three isoforms of Shc (17).
We have identified Tyr-471 as a critical phosphotyrosine residue of
DDR2 required for Shc interaction, among the 14 tyrosines in the
intracellular domain. As shown in Fig. 8, a Y471F mutation and/or
kinase-dead K608E dramatically decreased Shc association; however, it
did not totally inhibit the association, which suggests there are still
other minor association sites with Shc.
Tyrosine-phosphorylated Shc can recruit Grb2/Sos through a binding
event between the Grb2 SH2 domain and Shc phosphotyrosine residues,
ultimately resulting in activation of Ras, the extracellular signal-regulated kinase cascade, and mitogenesis (28). Interestingly, we have recently observed that fibroblasts in DDR2 Prior to the identification of DDR2 as a collagen receptor, cell
interactions with collagen had been ascribed primarily to integrins, a
family of heterodimeric receptors composed of We thank Dr. J. A. Cooper for the yeast
two-hybrid plasmids.
*
This work was supported by grants from the American Liver
Foundation (to K. I.) and Public Health Service Grant RO1 56621 from the NIDDK, National Institutes of Health (to S. L. F.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: Dept. of Anatomy, Graduate School of Medicine,
Osaka City University, Osaka 545-8585, Japan.
§§
To whom correspondence should be addressed: Box 1123, Mount Sinai
School of Medicine, 1425 Madison Ave., Rm. 1170F, New York, NY 10029. Tel.: 212-659-9501; Fax: 212-849-2574; E-mail:
frieds02@doc.mssm.edu.
Published, JBC Papers in Press, March 7, 2002, DOI 10.1074/jbc.M201078200
The abbreviations used are:
RTK, receptor
tyrosine kinase;
CA Src, constitutively active Src;
DDR, discoidin
domain receptor;
DN Src, dominant negative Src;
MMP-2, matrix
metalloproteinase-2;
mPAL, mouse protein expressed in activated
lymphocytes;
PDGF, platelet-derived growth factor;
WB, Western blot;
Ab, antibody;
PTB, phosphotyrosine binding;
SH, Src homology;
CH, collagen homology.
Discoidin Domain Receptor 2 Interacts with Src and Shc following
Its Activation by Type I Collagen*
§,
,
,
,
,
§§, and
Department of Medicine, Division of Liver
Diseases, Mount Sinai School of Medicine, New York, New York 10029, ¶ Regeneron Pharmaceuticals, Tarrytown, New York 10591-6707, the
Developmental Biology Program, European Molecular Biology
Laboratory, Meyerhofstrasse 1, 69117 Heidelberg, Germany, and the
** Department of Medicine, University of California, San
Francisco Veterans Affairs Medical Center,
San Francisco, California 94121
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
, Src, Shc, and
phosphatidylinositol 3-kinase. However, it is still unknown which
molecules interact with DDR2.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
, +/
, or wild type
littermate mice and immortalized with SV40 large T antigen. COS7 and
SYF were obtained from American Tissue Culture Collection. DDR2
/
skin fibroblasts were reconstituted by retroviral infection with green
fluorescent protein, wild type mouse DDR2, or a K608E point mutation to
produce a kinase-dead DDR2 (9).
-mercaptoethanol) at 55 °C for 30 min prior to
reprobing with different primary antibodies.
-galactosidase filter assay.
-galactosidase assay.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
and
chains (13). Moreover, integrin
clustering by collagen activates focal adhesion kinase and its
downstream signals (Src, Fyn, phosphatidylinositol 3-kinase, etc).
Among them, Src is a non-receptor tyrosine kinase of 60 kDa. Therefore,
Western blot for Src was performed after immunoprecipitation by the
DDR2 antibody. This analysis indicated that Src is associated with DDR2
in stellate cells prior to stimulation with exogenous collagen (Fig. 1,
lane 5), and that increased association seems to occur
following collagen stimulation (Fig. 1, lane 6). No specific bands were visible when immunoprecipitation was performed with control
antibody (Fig. 1, lanes 7 and 8).

View larger version (47K):
[in a new window]
Fig. 1.
Expression of endogenous DDR2 and its
association with c-Src in hepatic stellate cells (HSC-T6).
Cultured HSC-T6 cells were stimulated with (lanes 2,
4, 6, and 8) or without (lanes
1, 3, 5, and 7) collagen type I
(20 µg/ml) for 2 h. Cell lysates were immunoprecipitated
(IP) by a polyclonal anti-DDR2 antibody (lanes
1-6) or control rabbit serum (lanes 7 and
8), followed by WB with anti-DDR2 (lanes 1 and
2), anti-phosphotyrosine (lanes 3 and
4), or anti-Src (lanes 5 and 6) as
described under "Experimental Procedures." Immunoprecipitation/WB
for anti-DDR2 confirmed DDR2 expression with and without collagen, and
WB with anti-phosphotyrosine demonstrated that DDR2 is phosphorylated
by exposure to type I collagen (arrowhead). Interestingly,
WB for anti-phosphotyrosine revealed another band of ~60 kDa
(asterisk). Furthermore, WB for anti-Src demonstrated that
Src associates with DDR2 in stellate cells stimulated with type I
collagen (arrow).

View larger version (39K):
[in a new window]
Fig. 2.
The Src kinase-specific inhibitor, SU6656,
inhibits DDR2 phosphorylation induced by collagen type I. DDR2-transfected COS7 cells were grown with collagen type I (20 µg/ml) in the presence of increasing concentrations of SU6656 for
2 h. Cell lysates were immunoprecipitated by anti-DDR2, followed
by Western blotting with anti-DDR2, or anti-phosphotyrosine as
described under "Experimental Procedures." SU6656 inhibited the
phosphorylation of DDR2 in response to collagen I in a
dose-dependent manner.

View larger version (51K):
[in a new window]
Fig. 3.
c-Src-dependent phosphorylation
of DDR2 in COS7 cells. FcDDR2 and CA Src (A) or DN Src
(B) were transiently expressed in COS7 cells. A,
receptor autophosphorylation was measured by Western blotting with
anti-phosphotyrosine and anti-DDR2 after protein A precipitation of
cell lysates. In CA Src-transfected cells, markedly increased tyrosine
phosphorylation of FcDDR2 (lane 4) was detectable compared
with that in COS7 cells transfected with only FcDDR2 (lane
3), with minimal expression still apparent in cells transfected
with the kinase-dead FcDDR2 mutant (FcDDR2KE) (lane 6).
B, in DN Src-transfected cells, the phosphorylation of
FcDDR2 (lane 4) was inhibited compared with that in COS7
cells transfected with only FcDDR2 (lane 3). C,
wild type DDR2 was cotransfected with (lanes 6 and
8) or without (lanes 5 and 7) DN Src
in COS 7 cells. These cells were stimulated with (lanes 7 and 8) or without (lanes 5 and 6)
collagen I for 2 h. Cell lysates were immunoprecipitated with
anti-DDR2, followed by Western blotting with anti-DDR2,
anti-phosphotyrosine as described under "Experimental Procedures."
Phosphorylation of DDR2 by collagen I stimulation was inhibited by DN
Src. D, to compare the autophosphorylation of FcDDR2 to DDR2
exposed to collagen, wild type DDR2 and FcDDR2 were cotransfected in
COS7 cells. These cells were stimulated with (lane 2) or
without (lane 1) collagen I for 2 h. Cell lysates were
immunoprecipitated with anti-DDR2, followed by Western blotting with
anti-DDR2, anti-phosphotyrosine as described under "Experimental
Procedures."

View larger version (28K):
[in a new window]
Fig. 4.
Diminished DDR2 phosphorylation following
collagen stimulation in Src-deficient cells. SYF and wild type
fibroblasts were stimulated with collagen type I for 0 min, 30 min,
1 h, and 2 h, respectively. Cells lysates were
immunoprecipitated with anti-DDR2, followed by Western blotting with
anti-DDR2 or anti-phosphotyrosine as described under "Experimental
Procedures." DDR2 phosphorylation by collagen stimulation was delayed
and decreased in SYF cells. Wt, control fibroblasts;
SYF, Src/Yes/Fyn triple-knockout cells.

View larger version (41K):
[in a new window]
Fig. 5.
Src-dependent association of DDR2
with Shc in yeast. The yeast two-hybrid system was utilized to
clone proteins that bind to the phosphorylated DDR2 cytoplasmic domain
in the presence of Src kinase. A, lysates of yeast cells
transformed control baits (pBTM116-lamin (lane 1),
pBTM116[src] (lane 2), and pBTM116-DDR2 (lane
3)), and cells expressing LexA-DDR2 cytoplasmic domain together
with Src (lane 4) were precipitated by anti-DDR2, followed
by WB with anti-LexA, anti-DDR2, and/or anti-phosphotyrosine.
Immunoblot with anti-LexA or anti-DDR2 demonstrated a band
corresponding to the expected size of the LexA-DDR2 cytoplasmic domain
fusion protein in the yeast transformed with either pBTM116-DDR2 or
pBTM116[src]-DDR2 bait vector (lanes 3 and 4);
however, phosphorylation was confined to the fusion protein
co-expressed with Src kinase (lane 4). By yeast two-hybrid
screening with DDR2 bait from human skeletal muscle cDNA library,
the Shc adaptor protein was cloned. B, Shc has three
isoforms (46, 52, and 66 kDa). The region of Shc identified by yeast
two-hybrid overlapped almost exactly with CH1 and SH2 domains, which
are included in all three isoforms. C, to determine whether
Src tyrosine kinase is necessary for Shc association with DDR2, cloned
Shc vector was cotransformed with each control bait vector or original
bait vector in L40 yeast and
-galactosidase assay was performed
again. The LexA DDR2 cytoplasmic domain fusion protein was able to
interact with Shc clone when Src was present.
-galactosidase activity (Fig.
5C). The LexA DDR2 cytoplasmic domain fusion protein
interacted with Shc only in the presence of Src.
-galactosidase assay demonstrated that full-length Shc and (CH1+SH2) domains interacted with DDR2 in the
presence of active Src kinase. This finding established that the
portion of Shc containing both the (CH1+SH2) domains is the minimal
region required to interact with phosphorylated DDR2. To eliminate the
possibility that SH2 domain is misfolded and does not associate with
DDR2 in yeast, we used a truncated mouse protein expressed in activated
lymphocytes (mPAL) as a positive control bait, which is known to
associates with Shc SH2 (18).
-Galactosidase assay demonstrated that
truncated mPAL associated with full-length Shc and Shc-SH2 (data not
shown).
Mapping of Shc domains required for interaction with the DDR2 fusion
protein in yeast two-hybrid

View larger version (35K):
[in a new window]
Fig. 6.
Association of DDR2 with Shc in mammalian
cells. Skin fibroblasts were isolated from DDR2 knockout mice and
immortalized by transfection with SV 40 large T antigen. DDR2
expression by the cells was reconstituted by retroviral infection with
either wild type mouse DDR2 (lanes 3 and 4) or a
kinase-dead DDR2 mutant (DDR2KE) (lanes 5 and 6).
These cells were each stimulated with (lanes 2,
4, and 6) or without (lanes 1,
3, and 5) collagen type I (20 µg/ml) for 2 h. Cell lysates were immunoprecipitated (IP) by anti-DDR2,
followed by WB with anti-DDR2, anti-phosphotyrosine, or anti-Shc as
described under "Experimental Procedures." Immunoprecipitation/WB
demonstrated that Shc associated with DDR2 only when cells expressing
wild type DDR2 were stimulated with collagen type I (lane
4). Shc association with DDR2 did not occur when cells expressing
the kinase-dead mutant were stimulated with collagen type I (lane
6).

View larger version (24K):
[in a new window]
Fig. 7.
Src kinase-dependent association
of DDR2 with Shc in mammalian cells. A, COS7 cells
transfected with empty vector (lane 1). FcDDR2 (lanes
3 and 4) and DN Src (lanes 2 and
4) were transiently expressed in COS7 cells. Cell lysates
were precipitated by protein A, followed by Western blotting with
anti-DDR2, anti-phosphotyrosine, or anti-Shc as described under
"Experimental Procedures." FcDDR2, which was dephosphorylated by DN
Src, did not support the Shc-DDR2 interaction (lane 4).
B, DDR2
/
(lane 1) and DDR2-reconstituted
DDR2
/
(lanes 2-5) skin fibroblasts were stimulated
with collagen type I for 2 h in the presence (lanes 4 and 5) or absence (lanes 1-3) of Src kinase
inhibitor SU6656. Cells lysates were precipitated by anti-DDR2,
followed by Western blotting with anti-DDR2, anti-phosphotyrosine, or
anti-Src as described under "Experimental Procedures." One or 3 µM SU6656, which did not completely inhibit the
phosphorylation of DDR2 by collagen stimulation, inhibited Shc-DDR2
interaction (lanes 4 and 5).

View larger version (59K):
[in a new window]
Fig. 8.
A Y471F mutation reduces the association of
DDR2 with Shc and Src. FcDDR2 (lanes 2 and
7), FcDDR2Y471F (lanes 3 and 8),
FcDDR2KE (lanes 4 and 9), or FcDDR2KEY471F
(lanes 5 and 10) were transiently expressed with
(lanes 6-10) or without (lanes 1-5) wild type
Src in COS7 cells. Cell lysates were precipitated by protein A,
followed by Western blotting with anti-phosphotyrosine, anti-DDR2, and
anti-Shc as described under "Experimental Procedures." The Y471F
mutant DDR2 (lanes 3 and 8) slightly decreased
its phosphorylation; however, the K608E,Y471F DDR2 double mutants
(lanes 5 and 10) dramatically decreased its
phosphorylation (arrowhead). Furthermore, Shc association
was dramatically decreased by the Y471F mutation
(arrow).
and
(19). 3) DDR1 associates with the Shc PTB
domain at a similar residue in its juxtamembrane region (20).
/
or DDR2 +/
skin
fibroblasts were transiently cotransfected with CA or DN Src expression
plasmid and a luciferase reporter cDNA, which incorporates 1686 bp
upstream of the translation start site of the MMP-2 gene. Cells were
cultured in the presence of collagen type I with or without Src kinase
inhibitor, SU6656 for 24 h after transfection. As shown in Fig.
9, MMP-2 promoter activity in DDR2 +/
cells was 10 times higher than that in DDR2
/
cells. Furthermore,
it was significantly up-regulated by CA Src and down-regulated by DN
Src or SU6656 in DDR2 +/
cells. A similar effect on MMP-2 promoter
activity was also identified in COS7 cells, which were cotransfected
with pMT21 plasmid with or without wild type DDR2.

View larger version (17K):
[in a new window]
Fig. 9.
DDR2 signaling mediates MMP-2 promoter
activity. A 1686-bp MMP-2 promoter cDNA driving a luciferase
reporter gene was transiently co-transfected along with CA Src
(CA), DN Src (DN), or a control vector
(C) into DDR2
/
or DDR2 +/
skin fibroblasts. Cells
were cultured in the presence of collagen type I (30 µg/ml) with or
without Src kinase inhibitor, SU6656 (S1, 1 µM
SU6656; S10, 10 µM SU6656) for 24 h after
transfection. Luciferase activity was measured as described under
"Experimental Procedures." Data are expressed as means ± S.D. of at least three different experiments. *, p < 0.05; **, p < 0.01 versus control of
DDR2 +/
skin fibroblasts.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
mice have a
reduced proliferative response compared with wild type littermates in a
skin wound healing model (9). Thus far, we do not have evidence
implicating DDR2 in the mitogen-activated protein kinase signaling
pathway. We have recently demonstrated a marked decrease in MMP-2
expression in DDR
/
fibroblasts compared with DDR2 +/
cells (21).
Therefore, we performed an MMP-2 promoter assay in the presence of CA
or DN Src in each of these cell types. MMP-2 promoter activity in DDR2
+/
cells was significantly higher than that in DDR2
/
cells, and
in DDR2 +/
cells was further up-regulated by CA Src but
down-regulated by DN Src or Src kinase inhibitor, SU6656.
and
chains,
which, among other activities, can up-regulate MMP-2 (29). It seems
possible that integrins and DDR2 are co-localized and aggregated as
they hold collagen as a common ligand, which may enable their signaling
pathways to converge downstream. Our findings support this notion by
demonstrating that the Src pathway, already known to be involved
downstream of integrin signaling, is requisite for maximal DDR2
tyrosine phosphorylation and for engagement of the Shc adaptor protein.
However, we could not establish a direct relationship between integrins
and the DDR2 signaling pathway (data not shown). Emerging insights into
DDR2 signaling pathways will be critical to understanding how this
receptor system interacts with other matrix receptors, as well as the
as-yet-unclear role of this receptor in mediating cellular responses to
matrix molecules in its environment.
![]()
ACKNOWLEDGEMENT
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Shrivastava, A.,
Radziejewski, C.,
Campbell, E.,
Kovac, L.,
McGlynn, M.,
Ryan, T. E.,
Davis, S.,
Goldfarb, M. P.,
Glass, D. J.,
Lemke, G.,
and Yancopoulos, G. D.
(1997)
Mol. Cell
1,
25-34[CrossRef][Medline]
[Order article via Infotrieve]
2.
Vogel, W.,
Gish, G. D.,
Alves, F.,
and Pawson, T.
(1997)
Mol. Cell
1,
13-23[CrossRef][Medline]
[Order article via Infotrieve]
3.
Alves, F.,
Vogel, W.,
Mossie, K.,
Millauer, B.,
Hofler, H.,
and Ullrich, A.
(1995)
Oncogene
10,
609-618[Medline]
[Order article via Infotrieve]
4.
Schlessinger, J.
(1997)
Cell
91,
869-872[CrossRef][Medline]
[Order article via Infotrieve]
5.
Olaso, E.,
Ikeda, K.,
Eng, F. J., Xu, L.,
Wang, L. H.,
Lin, H. C.,
and Friedman, S. L.
(2001)
J. Clin. Invest.
108,
1369-1378[CrossRef][Medline]
[Order article via Infotrieve]
6.
Pawson, T.
(1995)
Nature
373,
573-580[CrossRef][Medline]
[Order article via Infotrieve]
7.
Vogel, S.,
Piantedosi, R.,
Frank, J.,
Lalazar, A.,
Rockey, D. C.,
Friedman, S. L.,
and Blaner, W. S.
(2000)
J. Lipid Res.
41,
882-893 8.
Klinghoffer, R. A.,
Sachsenmaier, C.,
Cooper, J. A.,
and Soriano, P.
(1999)
EMBO J.
18,
2459-2471[CrossRef][Medline]
[Order article via Infotrieve]
9.
Labrador, J. P.,
Azcoitia, V.,
Tuckermann, J.,
Lin, C.,
Olaso, E.,
Manes, S.,
Bruckner, K.,
Goergen, J. L.,
Lemke, G.,
Yancopoulos, G.,
Angel, P.,
Martinez, C.,
and Klein, R.
(2001)
EMBO Rep.
2,
446-452[Medline]
[Order article via Infotrieve]
10.
Keegan, K.,
and Cooper, J. A.
(1996)
Oncogene
12,
1537-1544[Medline]
[Order article via Infotrieve]
11.
Harendza, S.,
Pollock, A. S.,
Mertens, P. R.,
and Lovett, D. H.
(1995)
J. Biol. Chem.
270,
18786-18796 12.
Ankoma-Sey, V.,
Matli, M.,
Chang, K. B.,
Lalazar, A.,
Donner, D. B.,
Wong, L.,
Warren, R. S.,
and Friedman, S. L.
(1998)
Oncogene
17,
115-121[CrossRef][Medline]
[Order article via Infotrieve]
13.
Hynes, R. O.
(1992)
Cell
69,
11-25[CrossRef][Medline]
[Order article via Infotrieve]
14.
Parsons, J. T.,
and Parsons, S. J.
(1997)
Curr. Opin. Cell Biol.
9,
187-192[CrossRef][Medline]
[Order article via Infotrieve]
15.
Blake, R. A.,
Broome, M. A.,
Liu, X., Wu, J.,
Gishizky, M.,
Sun, L.,
and Courtneidge, S. A.
(2000)
Mol. Cell. Biol.
20,
9018-9027 16.
Pawson, T.,
and Gish, G. D.
(1992)
Cell
71,
359-362[CrossRef][Medline]
[Order article via Infotrieve]
17.
Pelicci, G.,
Lanfrancone, L.,
Grignani, F.,
McGlade, J.,
Cavallo, F.,
Forni, G.,
Nicoletti, I.,
Pawson, T.,
and Pelicci, P. G.
(1992)
Cell
70,
93-104[CrossRef][Medline]
[Order article via Infotrieve]
18.
Schmandt, R.,
Liu, S. K.,
and McGlade, C. J.
(1999)
Oncogene
18,
1867-1879[CrossRef][Medline]
[Order article via Infotrieve]
19.
Mori, S.,
Ronnstrand, L.,
Yokote, K.,
Engstrom, A.,
Courtneidge, S. A.,
Claesson-Welsh, L.,
and Heldin, C. H.
(1993)
EMBO J.
12,
2257-2264[Medline]
[Order article via Infotrieve]
20.
Vogel, W.
(1999)
FASEB J.
13,
S77-S82[Medline]
[Order article via Infotrieve]
21.
Olaso, E.,
Labrador, P.,
Wang, L.,
Ikeda, K.,
Eng, F. J.,
Klein, R.,
Lovett, D. H.,
Lin, H. C.,
and Friedman, S. L.
(2002)
J. Biol. Chem.
277,
3606-3613 22.
Takeichi, M.
(1995)
Curr. Opin. Cell Biol.
7,
619-627[CrossRef][Medline]
[Order article via Infotrieve]
23.
Rosen, S. D.,
and Bertozzi, C. R.
(1994)
Curr. Opin. Cell Biol.
6,
663-673[CrossRef][Medline]
[Order article via Infotrieve]
24.
Aplin, A. E.,
Howe, A.,
Alahari, S. K.,
and Juliano, R. L.
(1998)
Pharmacol. Rev.
50,
197-263 25.
Thomas, S. M.,
and Brugge, J. S.
(1997)
Annu. Rev. Cell Dev. Biol.
13,
513-609[CrossRef][Medline]
[Order article via Infotrieve]
26.
Vogel, W.,
Brakebusch, C.,
Fassler, R.,
Alves, F.,
Ruggiero, F.,
and Pawson, T.
(2000)
J. Biol. Chem.
275,
5779-5784 27.
van der Geer, P.,
Wiley, S.,
Gish, G. D.,
and Pawson, T.
(1996)
Curr. Biol.
6,
1435-1444[CrossRef][Medline]
[Order article via Infotrieve]
28.
Sternberg, P. W.,
and Alberola-Ila, J.
(1998)
Cell
95,
447-450[CrossRef][Medline]
[Order article via Infotrieve]
29.
Ellerbroek, S. M.,
Fishman, D. A.,
Kearns, A. S.,
Bafetti, L. M.,
and Stack, M. S.
(1999)
Cancer Res.
59,
1635-1641
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. L. Friedman Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver Physiol Rev, January 1, 2008; 88(1): 125 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-P. Han, C. Yan, L. Zhou, L. Qin, and H. Tsukamoto A Matrix Metalloproteinase-9 Activation Cascade by Hepatic Stellate Cells in Trans-differentiation in the Three-dimensional Extracellular Matrix J. Biol. Chem., April 27, 2007; 282(17): 12928 - 12939. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Shafiei and D. C. Rockey The Role of Integrin-linked Kinase in Liver Wound Healing J. Biol. Chem., August 25, 2006; 281(34): 24863 - 24872. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Wall, E. Werner, Z. Werb, and Y. A. DeClerck Discoidin Domain Receptor 2 Mediates Tumor Cell Cycle Arrest Induced by Fibrillar Collagen J. Biol. Chem., December 2, 2005; 280(48): 40187 - 40194. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yang, J. H. Kim, H. J. Kim, I.-S. Park, I. Y. Kim, and B.-S. Yang Tyrosine 740 Phosphorylation of Discoidin Domain Receptor 2 by Src Stimulates Intramolecular Autophosphorylation and Shc Signaling Complex Formation J. Biol. Chem., November 25, 2005; 280(47): 39058 - 39066. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Kang, K. Morimura, E. I. Salim, H. Wanibuchi, S. Yamaguchi, and S. Fukushima Persistence of Liver Cirrhosis in Association with Proliferation of Nonparenchymal Cells and Altered Location of {alpha}-Smooth Muscle Actin-Positive Cells Toxicol Pathol, April 1, 2005; 33(3): 329 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Heiska and O. Carpen Src Phosphorylates Ezrin at Tyrosine 477 and Induces a Phosphospecific Association between Ezrin and a Kelch-Repeat Protein Family Member J. Biol. Chem., March 18, 2005; 280(11): 10244 - 10252. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Xu, A Y Hui, E Albanis, M J Arthur, S M O'Byrne, W S Blaner, P Mukherjee, S L Friedman, and F J Eng Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis Gut, January 1, 2005; 54(1): 142 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Abdulhussein, C. McFadden, P. Fuentes-Prior, and W. F. Vogel Exploring the Collagen-binding Site of the DDR1 Tyrosine Kinase Receptor J. Biol. Chem., July 23, 2004; 279(30): 31462 - 31470. [Abstract] [Full Text] [PDF] |
||||
| ||||||||